Blossomhill Therapeutics, Inc. (BLSM)
13.50
+1.15
(+9.31%)
USD |
NASDAQ |
Nov 06, 16:00
13.50
0.00 (0.00%)
After-Hours: 20:00
Blossomhill Therapeutics EPS Diluted (Quarterly) : -0.7475 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7475 |
| March 31, 2026 | -0.6609 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.4167 |
| March 31, 2025 | -0.3296 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IGC Pharma, Inc. | -0.0187 |
| Cocrystal Pharma, Inc. | -0.2295 |
| CNBX Pharmaceuticals, Inc. | -0.0001 |
| Arvinas, Inc. | -0.8242 |
| Fulcrum Therapeutics, Inc. | -0.3433 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.76M |
| Total Expenses (Quarterly) | 23.76M |
| Enterprise Value | 613.91M |
| Earnings Yield | -15.96% |
| Normalized Earnings Yield | -15.96 |